Your Cart is Empty

"Together" - A film that will investigate LDN as a treatment for Autism in children

In 2022 we hope to produce our next documentary that will investigate the treatment of Autism in children and how it can be treated with Low Dose Naltrexone (LDN).

Your donation will allow us to interview the worlds leading doctors currently using this treatment and produce a film that is sure to be essential viewing for medical practitioners but possibly a life changing discovery for parents who could discover a new pathway forward for their child.

The film will examine thoughts on why Autism is on the rise, which factors may be causing this epidemic and how LDN might be successfully utilised in a low cost, safe, treatment regime.

Donations contribute towards the complete costs of production including research time, travel, editing costs, music licensing and marketing of the end product globally.

We are seeking $40,000 and expect to start production in January 2022.

Please donate if you would like to support us, every single dollar will help.

We are also offering one person or organisation the opportunity to sponsor the film. This will give them - credit at the opening and closing of the film, a sneak preview 7 days before the public see it and the rights to publicise their support on their own marketing platforms.


* indicates required
Which Mailing List Would you like to join? *

LDN Research Trust will use the information you provide on this form to enable us to email you to provide, newsletters, events, announcements and marketing materials. Please tick the email boxes below.

You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at contact@ldnresearchtrust.org. We will treat your information with respect. For more information about our privacy practices please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.